Cite
HARVARD Citation
Mlak, R. et al. (2019). Polymorphisms in the promotor region of the CRBN gene as a predictive factor for peripheral neuropathy in the course of thalidomide‐based chemotherapy in multiple myeloma patients. British journal of haematology. pp. 695-705. [Online].